82 related articles for article (PubMed ID: 20039306)
1. Does TLR2 regulate intestinal inflammation?
Mowat AM
Eur J Immunol; 2010 Feb; 40(2):318-20. PubMed ID: 20039306
[TBL] [Abstract][Full Text] [Related]
2. TLR2-independent induction and regulation of chronic intestinal inflammation.
Boulard O; Asquith MJ; Powrie F; Maloy KJ
Eur J Immunol; 2010 Feb; 40(2):516-24. PubMed ID: 19950179
[TBL] [Abstract][Full Text] [Related]
3. Loss of Toll-like receptor 2 and 4 leads to differential induction of endoplasmic reticulum stress and proapoptotic responses in the intestinal epithelium under conditions of chronic inflammation.
Messlik A; Schmechel S; Kisling S; Bereswill S; Heimesaat MM; Fischer A; Göbel U; Haller D
J Proteome Res; 2009 Oct; 8(10):4406-17. PubMed ID: 19681597
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter hepaticus infection triggers inflammatory bowel disease in T cell receptor alphabeta mutant mice.
Chin EY; Dangler CA; Fox JG; Schauer DB
Comp Med; 2000 Dec; 50(6):586-94. PubMed ID: 11200563
[TBL] [Abstract][Full Text] [Related]
5. Role of regulatory T cells in gastrointestinal inflammatory disease.
van Driel IR; Ang DK
J Gastroenterol Hepatol; 2008 Feb; 23(2):171-7. PubMed ID: 18289352
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells.
Uno K; Kato K; Atsumi T; Suzuki T; Yoshitake J; Morita H; Ohara S; Kotake Y; Shimosegawa T; Yoshimura T
Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G1004-12. PubMed ID: 17855767
[TBL] [Abstract][Full Text] [Related]
7. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
[TBL] [Abstract][Full Text] [Related]
8. Innate immunity in inflammatory bowel disease: state of the art.
Hisamatsu T; Ogata H; Hibi T
Curr Opin Gastroenterol; 2008 Jul; 24(4):448-54. PubMed ID: 18622158
[TBL] [Abstract][Full Text] [Related]
9. Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4.
Klein M; Obermaier B; Angele B; Pfister HW; Wagner H; Koedel U; Kirschning CJ
J Infect Dis; 2008 Oct; 198(7):1028-36. PubMed ID: 18700834
[TBL] [Abstract][Full Text] [Related]
10. Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease.
Uhlig HH; Powrie F
Eur J Immunol; 2009 Aug; 39(8):2021-6. PubMed ID: 19672896
[TBL] [Abstract][Full Text] [Related]
11. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
12. VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4.
Arranz A; Juarranz Y; Leceta J; Gomariz RP; Martínez C
Peptides; 2008 Jun; 29(6):948-56. PubMed ID: 18359536
[TBL] [Abstract][Full Text] [Related]
13. TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection.
Loures FV; Pina A; Felonato M; Calich VL
J Immunol; 2009 Jul; 183(2):1279-90. PubMed ID: 19553529
[TBL] [Abstract][Full Text] [Related]
14. Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP.
Gomariz RP; Arranz A; Abad C; Torroba M; Martinez C; Rosignoli F; Garcia-Gómez M; Leceta J; Juarranz Y
J Leukoc Biol; 2005 Aug; 78(2):491-502. PubMed ID: 15857940
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide-binding-oligomerization domain proteins and toll-like receptors: sensors of the inflammatory bowel diseases' microbial environment.
Mueller T; Podolsky DK
Curr Opin Gastroenterol; 2005 Jul; 21(4):419-25. PubMed ID: 15930981
[TBL] [Abstract][Full Text] [Related]
16. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
[TBL] [Abstract][Full Text] [Related]
17. A paradigm for commensalism: the role of a specific microbial polysaccharide in health and disease.
Kasper DL
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():1-8; discussion 8-10, 251-7. PubMed ID: 19710511
[TBL] [Abstract][Full Text] [Related]
18. The importance of Toll-like receptor 2 polymorphisms in severe infections.
Texereau J; Chiche JD; Taylor W; Choukroun G; Comba B; Mira JP
Clin Infect Dis; 2005 Nov; 41 Suppl 7():S408-15. PubMed ID: 16237639
[TBL] [Abstract][Full Text] [Related]
19. IL-10 gene-deficient mice lack TGF-beta/Smad-mediated TLR2 degradation and fail to inhibit proinflammatory gene expression in intestinal epithelial cells under conditions of chronic inflammation.
Ruiz PA; Shkoda A; Kim SC; Sartor RB; Haller D
Ann N Y Acad Sci; 2006 Aug; 1072():389-94. PubMed ID: 17057220
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells and Toll-like receptors in tumor immunity.
Wang RF; Peng G; Wang HY
Semin Immunol; 2006 Apr; 18(2):136-42. PubMed ID: 16469504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
